Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure-Reference-Cited by-同舟云学术

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure

Published:2018-02 Issue:2 Volume:11 Page:
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Sangaralingham Lindsey R.¹,Sangaralingham S. Jeson¹,Shah Nilay D.¹,Yao Xiaoxi¹,Dunlay Shannon M.¹

Affiliation:

1. From the Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery (L.R.S., N.D.S., X.Y.), Department of Cardiovascular Medicine (S.J.S., S.M.D.), and Department of Health Sciences Research (N.D.S., X.Y., S.M.D.), Mayo Clinic, Rochester, MN; and OptumLabs, Cambridge, MA (N.D.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

2. Understanding the Epidemic of Heart Failure: Past, Present, and Future

3. Trends in Heart Failure Incidence and Survival in a Community-Based Population

4. Drug discovery for heart failure: a new era or the end of the pipeline?

5. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacubitril-Valsartan in Patients Requiring Hemodialysis;JAMA Network Open;2024-08-20

2. Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin;European Journal of Clinical Pharmacology;2024-06-10

3. Costs of care and financial hardship among patients with heart failure;American Heart Journal;2024-03

4. Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity;Current Atherosclerosis Reports;2023-12

5. Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF;ESC Heart Failure;2023-12